William Powers
Pulmonary Disease · Knoxville, TNNPI 1093787590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by GSK at 24.2% of the total. Reporting peaked in 2019 at $954 and has fallen 97.1% since, to $27 in 2023. That places this record below the midpoint for pulmonary disease clinicians in TN, where the typical reported total is $3,628.
Across 144 payments — averaging $13.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$470
- Insmed, Inc.$252
- Genentech USA, Inc.$250
- Actelion Pharmaceuticals US, Inc.$211
- Boehringer Ingelheim$134
- AbbVie$130
- plus $494 from 10 others
What the payments were for
- Food & beverage$1,938100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 42 | $470 |
| Insmed, Inc. | 19 | $252 |
| Genentech USA, Inc. | 20 | $250 |
| Actelion Pharmaceuticals US, Inc. | 16 | $211 |
| Boehringer Ingelheim | 8 | $134 |
| AbbVie(2 entities) | 8 | $130 |
| Grifols USA, LLC | 8 | $123 |
| AstraZeneca(2 entities) | 7 | $91 |
| Mylan Specialty L.p. | 4 | $58 |
| Inogen, Inc. | 2 | $56 |
| Merck | 3 | $54 |
| United Therapeutics Corporation | 2 | $41 |
| Novartis | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Advanced Respiratory, Inc | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,941 in reported general payments places this provider in the 40th percentile of 339 pulmonary disease providers in Tennessee.
Other pulmonary disease in Knoxville
- John SwisherKnoxville$234K
- John PrinceKnoxville$117K
- Rajiv DhandKnoxville$96K
- Varun ShahKnoxville$64K
- Benjamin BevillKnoxville$31K
- Shannon ByrdKnoxville$23K
- James PharaohKnoxville$20K
- Isaac BineyKnoxville$16K
- Lisa LancasterNashville$519K
- Krishnendu BhadraChattanooga$494K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.